Literature DB >> 8422147

Can efficiency of follow-up for superficial bladder cancer be increased?

M C Gulliford1, A Petruckevitch, P G Burney.   

Abstract

This study evaluated the efficiency with which follow-up cystoscopy was employed in a population-based cohort of patients with superficial bladder cancer. Subjects were 240 men, aged under 75 years, with superficial bladder cancer first diagnosed in 1982. The median duration of follow-up was 6.1 years. The median (interquartile range) number of follow-up cystoscopies was 8 (5-12) per patient with a patient-specific annual rate of 1.7 (1.2-2.2) per year. The median number of cystoscopies at which recurrent tumour was detected was 2 (0-5) per patient, patient-specific annual rate 0.4 (0.0-1.3) per year of follow-up. Among patients with a single tumour at diagnosis and a negative first check cystoscopy (MRC group 1), the proportion of positive cystoscopies was 0.1 (0.0-0.4). Comparison of observed intervals between cystoscopies with optimal intervals calculated using an optimisation model showed that patients in MRC group 1 were seen sooner in practice than the model predicted, while in practice other patients were seen later than the model predicted. These data support the suggestion that efficiency of follow-up for patients with superficial bladder cancer could be increased by dividing patients into groups with different risks of recurrence and differing follow-up requirements.

Entities:  

Mesh:

Year:  1993        PMID: 8422147      PMCID: PMC2497742     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  9 in total

1.  Prognostic factors in infiltrating bladder cancer.

Authors:  B Richards; Y Aso; C Bollack; S Fossa; W Koontz; M Matsuda; K Matsumoto; G Prout; B Van der Werf-Messing; H Wolf
Journal:  Prog Clin Biol Res       Date:  1986

2.  The analysis of results in prophylactic superficial bladder cancer studies.

Authors:  R Sylvester
Journal:  Prog Clin Biol Res       Date:  1985

3.  Cancer follow up: time for review.

Authors:  H Smedley; K Sikora
Journal:  J R Coll Gen Pract       Date:  1985-10

4.  Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

Authors:  M K Parmar; L S Freedman; T B Hargreave; D A Tolley
Journal:  J Urol       Date:  1989-08       Impact factor: 7.450

5.  Management importance of common treatments: contribution of top 20 procedures to surgical workload and cost.

Authors:  B W Ellis
Journal:  BMJ       Date:  1991-04-13

6.  Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment.

Authors:  M C Gulliford; A Petruckevitch; P G Burney
Journal:  BMJ       Date:  1991-08-24

7.  Efficient scheduling of cystoscopies in monitoring for recurrent bladder cancer.

Authors:  D L Kent; R Shachter; H C Sox; N S Hui; L D Shortliffe; S Moynihan; F M Torti
Journal:  Med Decis Making       Date:  1989 Jan-Mar       Impact factor: 2.583

8.  Value of routine follow up of women treated for early carcinoma of the breast.

Authors:  J A Dewar; G R Kerr
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-23

9.  The impact of guidelines in clinical outpatient practice.

Authors:  R Hall; C J Roberts; G A Coles; D J Fisher; F G Fowkes; J H Jones; G S Kilpatrick; J H Lazarus; M F Scanlon; J P Thomas
Journal:  J R Coll Physicians Lond       Date:  1988-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.